Aimei Health Technology reported asset growth of -83.60% for the quarter ended Dec 2025. These growth metrics cover 8 quarters of results from Mar 2024 through Dec 2025, standardized by Business Quant from the company’s SEC filings.
| Growth Metrics | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 |
|---|---|---|---|---|---|---|---|---|
| Growth Ratios | ||||||||
| Assets Growth (1y) | 4.75% | -38.83% | -38.05% | -37.53% | -83.60% | |||
| Assets (QoQ) | 1.15% | 0.90% | 1.20% | 1.42% | -40.93% | 2.19% | 2.05% | -73.38% |
| Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y) | -95.14% | -98.22% | -98.64% | 141.41% | -89.62% | |||
| Cash & Equivalents (QoQ)Cash & Equiv. (QoQ) | -28.75% | -61.93% | -34.25% | -72.76% | -73.96% | -70.89% | 11,593.17% | -98.83% |
| Cash from Investing Activities (QoQ)Cash from Investing (QoQ) | -101.46% | 0.00% | ||||||
| Cash from Operations Growth (1y)Cash from Ops. Growth (1y) | -34.16% | 21.27% | -78.16% | |||||
| Cash from Operations (QoQ)Cash from Ops. (QoQ) | -53.47% | 78.95% | -261.72% | -14.80% | 9.94% | 52.36% | ||
| EBIT Growth (1y) | -169.09% | 86.54% | 34.93% | |||||
| EBIT (QoQ) | -101.20% | 35.29% | -100.99% | -2.83% | 89.94% | -212.84% | ||
| EBT Growth (1y) | -169.09% | 86.54% | 34.93% | |||||
| EBT (QoQ) | -101.20% | 35.29% | -100.99% | -2.83% | 89.94% | -212.84% | ||
| EPS (Basic) Growth (1y) | -841.88% | 80.16% | -193.97% | |||||
| EPS (Basic) (QoQ) | -101.20% | 35.29% | -100.99% | -259.94% | 95.76% | -858.57% | ||
| EPS (Diluted) Growth (1y) | -233.48% | 80.16% | 4.06% | |||||
| EPS (Diluted) (QoQ) | -101.20% | 35.29% | -100.99% | -27.44% | 88.03% | -212.84% | ||
| Free Cash Flow Growth (1y)FCF Growth (1y) | -34.16% | 21.27% | -78.16% | |||||
| Free Cash Flow (QoQ)FCF (QoQ) | -53.47% | 78.95% | -261.72% | -14.80% | 9.94% | 52.36% | ||
| Net Cash Flow Growth (1y)NCF Growth (1y) | 87.50% | 97.97% | 101.56% | |||||
| Net Cash Flow (QoQ)NCF (QoQ) | -53.47% | 78.95% | -261.72% | 89.31% | 75.04% | 116.15% | ||
| Net Income Growth (1y) | -169.09% | 86.54% | 34.93% | |||||
| Net Income (QoQ) | -101.20% | 35.29% | -100.99% | -2.83% | 89.94% | -212.84% | ||
| Net Income towards Common Stockholders Growth (1y)Net Income Growth (1y) | -169.09% | 86.54% | 34.93% | |||||
| Net Income towards Common Stockholders (QoQ)Net Income (QoQ) | -101.20% | 35.29% | -100.99% | -2.83% | 89.94% | -212.84% | ||
| Operating Income Growth (1y)Op. Inc Growth (1y) | -169.09% | 86.54% | 34.93% | |||||
| Operating Income (QoQ)Op. Inc (QoQ) | -101.20% | 35.29% | -100.99% | -2.83% | 89.94% | -212.84% | ||
| Profit After Tax Growth (1y)PAT Growth (1y) | -75.56% | -30.23% | -52.65% | |||||
| Profit After Tax (QoQ)PAT (QoQ) | -19.38% | 22.07% | -40.27% | -58.42% | 130.13% | -17.17% | ||
| Return on Assets [ROA] (QoQ)ROA (QoQ) | -80.00 | -14.00 | 20.00 | |||||
| Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ) | -85.00 | -20.00 | 19.00 | |||||
| Total Debt Growth (1y) | 788.92% | |||||||
| Total Debt (QoQ) | 231.75% | 59.57% | 37.33% | 22.27% |